Coxsackie viruses and diabetes

Insulinoma--experience from 1950 to 1995.

The Western journal of medicine·1998

Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatment.

Journal of controlled release : official journal of the Controlled Release Society·1998

Chronic sympathetic innervation of islets in transgenic mice results in differential desensitization of alpha-adrenergic inhibition of insulin secretion.

Advances in experimental medicine and biology·1997

Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus.

Journal of clinical pharmacology·1996

Reversible insulin resistance in non-insulin-dependent diabetes mellitus.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·1996

Constitutive (pro)insulin release from pancreas of transgenic mice expressing monomeric insulin.

Endocrinology·1995

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Multifactorial Chylomicronemia Syndrome With a Rare APOA5 Variant and Recurrent Acute Pancreatitis: A Case Report From Rural Colombia.

Cureus·2026

Culturally Meaningful End-of-Life Care for a Patient With Cancer of Unknown Primary, and Severe Motor and Intellectual Disabilities: A Case Report.

Cureus·2026

The glioblastoma ecosystem: clonal evolution, heterogeneity, and therapeutic resistance.

Frontiers in cell and developmental biology·2026

Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review.

Frontiers in oncology·2026

The gut microbiota in colorectal cancer: role in cytokine regulation, intestinal immune barrier dysfunction.

Frontiers in oncology·2026

The role and application prospects of glycolysis-related non-coding RNAs in lung cancer.

Journal of translational medicine·2026

Related Experiment Videos

Coxsackie viruses and diabetes

Related Concept Videos

Insulinoma--experience from 1950 to 1995.

Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatment.

Chronic sympathetic innervation of islets in transgenic mice results in differential desensitization of alpha-adrenergic inhibition of insulin secretion.

Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus.

Reversible insulin resistance in non-insulin-dependent diabetes mellitus.

Constitutive (pro)insulin release from pancreas of transgenic mice expressing monomeric insulin.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Multifactorial Chylomicronemia Syndrome With a Rare APOA5 Variant and Recurrent Acute Pancreatitis: A Case Report From Rural Colombia.

Culturally Meaningful End-of-Life Care for a Patient With Cancer of Unknown Primary, and Severe Motor and Intellectual Disabilities: A Case Report.

The glioblastoma ecosystem: clonal evolution, heterogeneity, and therapeutic resistance.

Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review.

The gut microbiota in colorectal cancer: role in cytokine regulation, intestinal immune barrier dysfunction.

The role and application prospects of glycolysis-related non-coding RNAs in lung cancer.

Related Experiment Videos

Coxsackie viruses and diabetes

Related Concept Videos

Related Articles